This company has been marked as potentially delisted and may not be actively trading. Tenzing Acquisition (TZAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TZAC vs. DRRX, LGVN, MRKR, LPCN, COCP, CING, GELS, LEXX, BFRG, and PMNShould you be buying Tenzing Acquisition stock or one of its competitors? The main competitors of Tenzing Acquisition include DURECT (DRRX), Longeveron (LGVN), Marker Therapeutics (MRKR), Lipocine (LPCN), Cocrystal Pharma (COCP), Cingulate (CING), Gelteq (GELS), Lexaria Bioscience (LEXX), Bullfrog AI (BFRG), and ProMIS Neurosciences (PMN). Tenzing Acquisition vs. Its Competitors DURECT Longeveron Marker Therapeutics Lipocine Cocrystal Pharma Cingulate Gelteq Lexaria Bioscience Bullfrog AI ProMIS Neurosciences DURECT (NASDAQ:DRRX) and Tenzing Acquisition (NASDAQ:TZAC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, community ranking, dividends, valuation and analyst recommendations. Does the MarketBeat Community favor DRRX or TZAC? DURECT received 316 more outperform votes than Tenzing Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformDURECTOutperform Votes31660.89% Underperform Votes20339.11% Tenzing AcquisitionN/AN/A Does the media prefer DRRX or TZAC? In the previous week, DURECT had 1 more articles in the media than Tenzing Acquisition. MarketBeat recorded 1 mentions for DURECT and 0 mentions for Tenzing Acquisition. DURECT's average media sentiment score of 1.89 beat Tenzing Acquisition's score of 0.00 indicating that DURECT is being referred to more favorably in the media. Company Overall Sentiment DURECT Very Positive Tenzing Acquisition Neutral Which has higher earnings and valuation, DRRX or TZAC? Tenzing Acquisition has lower revenue, but higher earnings than DURECT. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDURECT$1.86M10.29-$27.62M-$0.15-4.10Tenzing AcquisitionN/AN/A$620KN/AN/A Do analysts rate DRRX or TZAC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DURECT 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Tenzing Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is DRRX or TZAC more profitable? Tenzing Acquisition has a net margin of 0.00% compared to DURECT's net margin of -198.58%. Tenzing Acquisition's return on equity of -13.32% beat DURECT's return on equity.Company Net Margins Return on Equity Return on Assets DURECT-198.58% -300.62% -65.17% Tenzing Acquisition N/A -13.32%-1.36% Do insiders and institutionals hold more shares of DRRX or TZAC? 28.0% of DURECT shares are owned by institutional investors. Comparatively, 60.9% of Tenzing Acquisition shares are owned by institutional investors. 3.2% of DURECT shares are owned by company insiders. Comparatively, 37.5% of Tenzing Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, DRRX or TZAC? DURECT has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Tenzing Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. SummaryDURECT and Tenzing Acquisition tied by winning 6 of the 12 factors compared between the two stocks. Get Tenzing Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for TZAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TZAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TZAC vs. The Competition Export to ExcelMetricTenzing AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$4.00M$6.88B$2.55B$8.50BDividend YieldN/A2.53%13.04%4.17%P/E RatioN/A8.5511.6519.64Price / SalesN/A262.613,130,852.97152.17Price / Cash143.1065.8561.1334.64Price / Book0.806.533.764.60Net Income$620K$143.48M-$466.93M$248.06M Tenzing Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TZACTenzing AcquisitionN/A$0.78-1.6%N/A-46.8%$4.00MN/A0.00N/AGap UpHigh Trading VolumeDRRXDURECT1.3465 of 5 stars$0.57+7.3%N/A-59.0%$17.76M$1.86M-0.9480Positive NewsGap DownLGVNLongeveron3.5307 of 5 stars$1.18-5.6%$8.67+634.5%-27.1%$17.62M$2.23M-0.1920Gap UpMRKRMarker Therapeutics4.2853 of 5 stars$1.52+7.8%$13.17+766.2%-57.8%$17.20M$6.59M-1.1460Positive NewsLPCNLipocine2.3266 of 5 stars$3.20-2.4%$9.00+181.3%-60.3%$17.12M$3.67M-4.2110News CoverageAnalyst ForecastAnalyst RevisionGap DownCOCPCocrystal Pharma2.6498 of 5 stars$1.68+1.8%$7.00+316.7%-45.0%$17.09MN/A-0.9110Short Interest ↑Gap UpCINGCingulate1.9415 of 5 stars$3.98flat$26.00+553.3%+535.7%$16.90MN/A-0.4720Short Interest ↑Gap DownGELSGelteqN/A$1.79+19.3%N/AN/A$16.89MN/A0.00N/ALEXXLexaria Bioscience2.5389 of 5 stars$0.92-5.7%$7.00+659.9%-68.5%$16.18M$525.92K-1.847News CoverageBFRGBullfrog AI1.6602 of 5 stars$1.71flatN/A-33.2%$16.10M$60K-2.014News CoveragePMNProMIS Neurosciences2.3518 of 5 stars$0.49-2.0%$4.50+818.4%-69.0%$16.02MN/A-4.905Positive News Related Companies and Tools Related Companies DURECT Competitors Longeveron Competitors Marker Therapeutics Competitors Lipocine Competitors Cocrystal Pharma Competitors Cingulate Competitors Gelteq Competitors Lexaria Bioscience Competitors Bullfrog AI Competitors ProMIS Neurosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TZAC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenzing Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenzing Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TZAC Stock Free TZAC Stock Alerts